A detailed history of Friess Associates LLC transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Friess Associates LLC holds 766,650 shares of ASRT stock, worth $682,318. This represents 3.78% of its overall portfolio holdings.

Number of Shares
766,650
Previous 1,196,452 35.92%
Holding current value
$682,318
Previous $3.43 Million 34.13%
% of portfolio
3.78%
Previous 1.83%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.88 - $3.42 $808,027 - $1.47 Million
-429,802 Reduced 35.92%
766,650 $2.26 Million
Q1 2022

May 12, 2022

BUY
$2.06 - $3.0 $651,891 - $949,356
316,452 Added 35.96%
1,196,452 $3.43 Million
Q4 2021

Feb 11, 2022

BUY
$0.86 - $2.3 $756,800 - $2.02 Million
880,000 New
880,000 $1.92 Million

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $42.9M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Friess Associates LLC Portfolio

Follow Friess Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Friess Associates LLC with notifications on news.